FTC & HHS INVESTIGATE GENERIC DRUG SHORTAGES AND MIDDLEMEN.
The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) have initiated an inquiry into the causes of generic drug shortages and the role of middlemen in the supply chain. This move follows recent concerns over drug shortages, particularly in oncology drugs, which have forced healthcare providers to ration critical medications. The investigation targets group purchasing organizations (GPOs) and drug distributors, questioning their influence on drug pricing, manufacturing, and supply to hospitals. Lawmakers have expressed worries about the power of these middlemen, citing their impact on market dynamics and potential disincentives for drug suppliers. The FTC’s inquiry aims to understand whether the concentration among intermediaries has hindered competition in the generic drug market. Industry responses vary, with trade groups welcoming the inquiry while emphasizing the need for action to ensure the long-term sustainability of generic manufacturing. GPOs have defended their role, highlighting their efforts to stabilize the market and ensure reliable drug supply. (New York Times)
SPACEX RETIRES 100 STARLINK SATELLITES OVER FLAW CONCERNS.
SpaceX has announced the retirement of around 100 Starlink satellites due to a flaw that increases the risk of failure. While this won’t affect service for Starlink users, the flaw could lead to a loss of control. Seventeen satellites are currently non-maneuverable, and although the exact reason is unspecified, unpowered satellites pose a debris risk. To mitigate this, SpaceX plans controlled descents over the next six months to remove them from orbit. Despite concerns about space debris, with nearly 6,000 satellites launched and 406 de-orbited, Starlink’s vast network remains operational. The retirement process will occur gradually, and any high-risk encounters with other satellites will be maneuvered to avoid collisions. Overall, while the retirement process aims to address safety concerns, it won’t impact Starlink’s ability to serve its customers. (TechCrunch)
If you’re enjoying the Daily Dose, sign up for the Daily Dose Newsletter and get the morning’s best science news from around the web delivered straight to your inbox? It’s easy like Sunday morning.
130+ LIVES LOST IN DEVASTATING WILDFIRES ACROSS LATIN AMERICA.
Wildfires in Chile, Colombia, and Argentina have claimed over 130 lives, with significant environmental devastation, including damage to UNESCO World Heritage Sites. Scientists attribute these unprecedented fires to a combination of factors: climate change, particularly amplified by a strong El Niรฑo pattern, non-native tree proliferation, and urban expansion into forested areas. Climate change-induced droughts and warmer temperatures exacerbate fire risks. Human activities, such as well-intentioned eucalyptus tree planting in Colombia and forest plantation expansion in Chile, provide ample fuel. Urgent preventive measures, including reducing fuel loads, building firebreaks, and promoting native species in urban-rural interfaces, are needed. However, implementing such strategies requires substantial legal and regulatory changes. Governments are urged to prioritize resilience-building efforts to mitigate the escalating risks posed by wildfires in Latin America. (Nature)
UPSIDE FOODS HALTS ILLINOIS PLANT PLANS, FOCUSES ON CALIFORNIA.
Upside Foods’ ambitious plans for a large cultivated-meat plant in Glenview, Illinois, dubbed “Rubicon,” have been put on hold. Instead, the company will double down on its Emeryville, California facility before resuming work in Glenview. The decision follows a challenging funding environment for the cultivated-meat industry, with investment dropping significantly from 2022 to 2023. Upside’s shift also reflects a broader trend of startups scaling up gradually to demonstrate production scalability. Despite setbacks, there are signs of progress in the industry, with regulatory approvals in Israel and ongoing processes in Australia and New Zealand. However, the sector faces challenges, including pushback from lawmakers in the US and Italy. Upside’s strategic shift is seen as a prudent move amidst the industry’s uncertain landscape, focusing on maximizing existing resources rather than committing to large-scale investments prematurely. (Wired)
PSYCHEDELIC THERAPY OFFERS HOPE AMIDST CANCER STRUGGLES.
Marjorie Smith faced challenges from leukemia and divorce, leading to depression until she learned about psilocybin’s potential to treat anxiety in similar patients. She participated in a clinical trial in Maryland, where she experienced a vivid psychedelic trip divided into three chapters related to her family, separation, and patience. While psilocybin didn’t cure her leukemia, it helped her regain positivity. Sunstone Therapies, where she received treatment, aims to provide relief to cancer patients’ existential anguish using psychedelics. Founded by oncologists Agrawal and Thambi, the center offers therapy rooms and safe treatments funded by donations. This resurgence of psychedelic therapy echoes the 1950s and 1960s but faces obstacles like pharmaceutical greed and potential trivialization. Despite concerns, advocates like MAPS founder Rick Doblin push for legalization, highlighting psychedelics’ potential in treating trauma. The movement faces challenges of scale, cost, and religious acceptance, but activists remain optimistic about the potential benefits of responsible psychedelic use. (El Pais)
INTUITIVE MACHINES LAUNCHES NOVA-C FOR HISTORIC LUNAR TOUCHDOWN.
A moon lander dubbed Nova-C, built by Houston-based aerospace company Intuitive Machines, was launched from Florida on a mission to accomplish the first US lunar touchdown in over 50 years and the first by a privately owned spacecraft. Lifted atop a SpaceX Falcon 9 rocket, the lander, nicknamed Odysseus, took off from NASA’s Kennedy Space Center after a 24-hour delay due to temperature irregularities in its propulsion system. Carrying six NASA payloads, the mission aims to gather data about the lunar environment ahead of NASA’s planned return of astronauts to the moon. The launch follows the recent failure of Astrobotic Technology’s lunar lander, highlighting the risks of commercial space ventures. If successful, Nova-C will mark the first controlled descent to the lunar surface by a US spacecraft since 1972, advancing NASA’s Artemis moon program, which envisions human exploration of Mars. The mission reflects NASA’s strategy of leveraging private spacecraft to reduce costs and accelerate lunar exploration efforts. (The Guardian)
COMMERCIAL SPACECRAFT LAUNCHES LUNAR OBSERVATORIES FOR ASTRONOMY.
A commercial spacecraft launched with two small observatories aimed at showcasing the Moon’s potential for astronomy. The International Lunar Observatory Association (ILOA) is behind the optical telescope, ILO-X, to prove lunar astronomy’s viability. Another instrument, ROLSES, a radio telescope, will study Earth’s reactions to solar events and search for an “electron sheath” above the lunar surface. These would be the first of their kind on the Moon. Astronomers anticipate benefits like reduced interference from Earth’s radio noise and improved visibility of infrared signals. Concerns exist about lunar development potentially disrupting scientific efforts. The mission, named IM-1, by Intuitive Machines, contracted by NASA’s Commercial Lunar Payload Services program, aims for a soft landing in the Malapert A crater. Alongside NASA payloads, the lander carries sculptures by Jeff Koons. ILO-X will image celestial objects, while ROLSES aims to study solar and lunar phenomena, potentially aiding exoplanet research and fundamental physics exploration. (Science)
Thanks for reading. Let’s be careful out there.
WORDS: The Biology Guy.
IMAGE CREDIT: Anna Shvets.
Leave a Reply